• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Some considerations for the planning of total-community prevention trials--when is sample size adequate?

作者信息

Gillum R F, Williams P T, Sondik E

出版信息

J Community Health. 1980 Summer;5(4):270-8. doi: 10.1007/BF01324196.

DOI:10.1007/BF01324196
PMID:6995504
Abstract

Despite the large accumulated experience of statisticians with sample-size calculations for clinical trials, little information is available on extending this methodology to total community trials, in which the units of randomization are total communities and surveillance methods are used to assess event rates. As in clinical trials, the asymptotic formula for total sample size is used. However, the assumptions underlying the usual method of computing the expected T-year even rate for the experimental group, pe, are no longer valid in total community trials: all emigrants (dropouts) from large communities cannot practically be identified or followed. Immigrants, similar to dropouts in clinical trials in that they are exposed to the treatment for only a portion of the period but are followed to the end of the study, present an additional problem. This paper presents a method for the computation of pe in total community trials, taking into account in- and out-migration as well as the determinants usually considered in clinical trials. Sample computations are presented, and general problems of design, execution and data analysis of total community prevention trials are briefly discussed.

摘要

相似文献

1
Some considerations for the planning of total-community prevention trials--when is sample size adequate?
J Community Health. 1980 Summer;5(4):270-8. doi: 10.1007/BF01324196.
2
On design considerations and randomization-based inference for community intervention trials.关于社区干预试验的设计考量及基于随机化的推断
Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q.
3
Sample sizes for prevention trials have been too small.
Am J Epidemiol. 1993 Apr 1;137(7):787-96. doi: 10.1093/oxfordjournals.aje.a116739.
4
Accounting for expected attrition in the planning of community intervention trials.在社区干预试验规划中考虑预期的受试者流失情况。
Stat Med. 2007 Jun 15;26(13):2615-28. doi: 10.1002/sim.2733.
5
Problems in publication of clinical trial methodology.
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):751-3. doi: 10.1002/cpt1979255part2751.
6
Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Problems of omission in communications.交流:是否应建立机制,让临床试验研究者分享在设计、实施和分析中处理问题的经验?交流中的遗漏问题。
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):761-4.
7
Curtailed binomial sampling procedures for clinical trials with paired data.用于配对数据临床试验的截尾二项抽样程序。
Control Clin Trials. 1985 Mar;6(1):25-37. doi: 10.1016/0197-2456(85)90094-7.
8
Statistical considerations in drug trials of peptic ulcer.消化性溃疡药物试验中的统计学考量
J Clin Gastroenterol. 1981;3(Suppl 2):135-40.
9
Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Methodology: the case for improved communications.交流:是否应建立机制,以便临床试验研究者之间分享在设计、实施和分析中处理问题的经验?方法:支持加强交流的理由。
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):754-7.
10
Interpretation of cancer prevention trials.癌症预防试验的解读
Prev Med. 1989 Sep;18(5):721-31. doi: 10.1016/0091-7435(89)90043-1.

本文引用的文献

1
The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problem.在存在失访或不依从问题的慢性病研究中,治疗组与对照组比较时样本量的确定。
J Chronic Dis. 1967 Apr;20(4):233-9. doi: 10.1016/0021-9681(67)90005-7.
2
Selected risk factors in coronary disease. Possible intervention effects.冠心病的选定风险因素。可能的干预效果。
Arch Environ Health. 1969 Sep;19(3):382-94. doi: 10.1080/00039896.1969.10666860.
3
Sample izes for medical trials with special reference to long-term therapy.
特别涉及长期治疗的医学试验样本量。
J Chronic Dis. 1968 Jan;21(1):13-24. doi: 10.1016/0021-9681(68)90082-9.
4
The North Karelia project: an attempt at community prevention of cardiovascular disease.北卡累利阿项目:社区预防心血管疾病的一次尝试。
WHO Chron. 1973 Feb;27(2):55-8.
5
A plea for a discipline of health and medical evaluation.对健康与医学评估学科的呼吁。
Int J Epidemiol. 1975 Mar;4(1):11-23. doi: 10.1093/ije/4.1.11.
6
Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group.美国国立心肺血液研究所多危险因素干预试验(MRFIT)中的统计设计考量。多危险因素干预试验小组。
J Chronic Dis. 1977 May;30(5):261-75. doi: 10.1016/0021-9681(77)90013-3.
7
Community surveillance for cardiovascular disease. Methods, problems, applications--a review.心血管疾病的社区监测。方法、问题与应用——综述
J Chronic Dis. 1978 Feb;31(2):87-94. doi: 10.1016/0021-9681(78)90093-0.
8
Community education for cardiovascular health.心血管健康的社区教育
Lancet. 1977 Jun 4;1(8023):1192-5. doi: 10.1016/s0140-6736(77)92727-1.